lipo-c dosage FAQ

Resume the protocol at the next scheduled injection. Do not double-dose to 'catch up'. Lipotropic compounds do not have a cumulative dose-response relationship; administering 2.0mL in a single injection does not produce twice the effect of 1.0mL. Missing a dose interrupts the steady-state plasma concentration but does not negate prior administrations. The most common mistake is attempting to compensate with back-to-back injections, which increases injection-site reactions without improving outcomes.

Mild discomfort lasting 10–15 minutes post-injection is normal and results from subcutaneous tissue expansion and pH differential (bacteriostatic water has a pH of 5.0–7.0; subcutaneous interstitial fluid is pH 7.4). Persistent pain beyond 30 minutes, or swelling that increases over 2–4 hours, suggests either incorrect injection depth (intramuscular instead of subcutaneous) or a hypersensitivity reaction to benzyl alcohol preservative. Rotate sites more frequently and reduce injection volume per site. If symptoms persist across multiple sites, consider switching to preservative-free sterile water for reconstitution.

Discard it immediately. Do not inject. Cloudiness indicates bacterial contamination or particulate matter from improper reconstitution. Discolouration (yellow, brown, or pink tint) suggests methionine oxidation or choline degradation. Neither is salvageable. Cloudiness can result from injecting water too forcefully during reconstitution, causing protein denaturation, or from introducing contaminants during vial access. Always use a fresh alcohol swab before every needle entry and never reuse needles between draws.

If the vial was at room temperature (20–25°C) for 8–12 hours, methionine oxidation likely reached 10–15%. The solution may still appear clear and normal, but bioactivity is compromised. For research applications requiring precise dosing, discard the vial and reconstitute a fresh one. For less stringent applications, the vial can still be used but with the understanding that potency is reduced. Temperature-excursion damage is not visually detectable. Methionine sulfoxide is colourless and remains in solution.

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 1250 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 1250 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Lipo-C is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

If you realize a miscalculation, it's critical to assess the impact immediately. Depending on the stage of your study and the magnitude of the error, you might need to discard affected data or, in severe cases, restart the experiment. Transparency and meticulous record-keeping are essential.

Evaluate dietary methionine and choline intake. Supplementation cannot overcome severe dietary deficiency. A 2017 study in the American Journal of Clinical Nutrition found that subjects consuming fewer than 250mg choline daily did not respond to lipotropic injections because baseline deficiency exceeded the supplemental dose. Increasing injection frequency from once to twice weekly may help, but if dietary intake remains below 400mg choline and 1g methionine daily, exogenous lipotropics will be consumed to meet basal requirements rather than supporting hepatic lipid export.

If the vial was at room temperature (20–25°C) for fewer than 12 hours, refrigerate immediately and use within the next seven days. If it was exposed to temperatures above 25°C or left unrefrigerated for more than 24 hours, discard it. Methionine oxidizes to methionine sulfoxide at elevated temperatures, and there's no way to visually confirm whether degradation has occurred. Oxidized LIPO-C looks identical to active compound but provides no methyl donor activity. Temperature excursions are the most common cause of ineffective lipotropic protocols, and using degraded compound wastes both the injection and the time you'd otherwise spend at therapeutic dosing.

Scale down to 0.25–0.5 mL per day to avoid cumulative B12 oversaturation while maintaining steady methionine replenishment. Daily administration prevents the methionine depletion seen in once-weekly protocols, but total weekly B12 intake should remain under 3500–4000mcg to stay within hepatic uptake capacity. A daily 0.25 mL dose of standard formulation delivers 250mcg B12 and 12.5mg methionine per injection. Totalling 1750mcg B12 and 87.5mg methionine weekly, which falls within validated ranges for sustained PEMT activity without renal B12 wastage.

Use 40–50mg methionine per injection maximum, paired with 50–100mg choline, and monitor homocysteine levels if the protocol extends beyond 4 weeks. Once-weekly dosing is suboptimal because methionine's plasma half-life is only 2.5 hours, though SAMe elevation persists 12–16 hours. Spacing doses 7 days apart creates SAMe troughs mid-week that reduce sustained lipotropic activity. If weekly dosing is unavoidable, consider adding B-vitamin cofactors (B6, B12, folate) to support homocysteine remethylation and prevent accumulation.

Increase to 1.5ml weekly for the next four-week cycle and verify B-vitamin cofactor status with methylmalonic acid (MMA) and homocysteine lab testing. If homocysteine is elevated (>10 µmol/L) despite LIPO-C dosing, the issue is cofactor deficiency. Not insufficient methyl donor intake. Add injectable methylcobalamin at 2,500mcg weekly and retest homocysteine after eight weeks. If MMA and homocysteine are both normal and no metabolic shift occurs at 1.5ml weekly, the bottleneck may be downstream. Insulin resistance, inadequate caloric deficit, or impaired fatty acid oxidation due to mitochondrial dysfunction unrelated to methyl donor availability.

Inositol itself rarely causes nausea, but rapid dose escalation. Particularly jumps from 50mg to 100mg in a single step. Can trigger mild GI upset in 10–15% of patients. This occurs because higher inositol doses accelerate bile acid synthesis and hepatic lipid mobilization, temporarily increasing intestinal fat content. Reducing the dose increment to 25mg steps and allowing 2 weeks between increases typically resolves the issue. If nausea persists beyond 48 hours at any dose, it's more likely attributable to the choline or methionine components in the formulation rather than inositol.

Reduce per-injection methionine to 25–40mg and increase frequency to 3× weekly instead. Doses above 50mg saturate methionine adenosyltransferase (MAT), the enzyme converting methionine to SAMe. Excess substrate is shunted into the transsulfuration pathway, producing homocysteine without additional SAMe synthesis. Research from the Journal of Hepatology confirms plasma methionine plateaus 90–120 minutes post-injection regardless of dose above 50mg, meaning higher doses waste compound and elevate cardiovascular risk markers.

If you miss a scheduled LIPO-C injection by fewer than 48 hours, administer the missed dose as soon as possible and resume the normal schedule. If more than 48 hours have passed, skip the missed dose and continue with the next scheduled injection. Do not double-dose. Missing doses during research protocols temporarily reduces SAMe availability, which can disrupt phosphatidylcholine synthesis and allow hepatic triglyceride accumulation. Consistency matters more than compensatory dosing.

Administer no more than 1.0mL per injection in research protocols. Doses above 1.0mL per injection do not proportionally increase methylation flux. The liver's SAMe synthetase enzyme saturates at methionine concentrations achievable with 1.0mL doses, meaning additional methionine is oxidised rather than converted to SAMe. Studies in hepatic metabolism show that methionine clearance follows Michaelis-Menten kinetics with a saturation threshold around 250–300 micromolar plasma concentration. Exceeding this threshold increases homocysteine levels without enhancing lipotropic benefit.

Start at 50mg twice weekly and measure fasting glucose and liver enzymes at baseline and week 6. If fasting glucose remains above 100mg/dL or ALT stays elevated, increase to 75mg. The dose-response relationship for inositol follows a threshold model rather than a linear curve. You'll know whether 50mg is sufficient within 4–6 weeks based on whether metabolic markers shift. Patients with insulin resistance typically plateau at 50mg and respond when increased to 75–100mg.

Reformulate to achieve methionine-to-choline ratios between 1:1 and 1:2 before proceeding. Methionine provides methyl groups for SAMe synthesis, but choline provides the substrate for phosphatidylcholine. The molecule that packages hepatic triglycerides into VLDL for export. A methionine-heavy formulation creates a methylation surplus with no downstream pathway to utilize it. Choline should equal or exceed methionine content in all LIPO-C protocols targeting hepatic lipid mobilization.

Reduce injection volume proportionally or add standalone methionine to maintain the 4:1–6:1 ratio. A 2500mcg/mL formulation delivering 1000mcg B12 in 0.4 mL only provides 25mg methionine if the lipotropic concentration wasn't adjusted. That's a 2.5:1 ratio, which leaves methionine synthase substrate-limited. The excess B12 saturates renal clearance without improving methyl donation. Either inject 0.2 mL (500mcg B12, closer to balanced ratio) or co-administer 25–30mg standalone L-methionine to bring the functional ratio back to 5:1.

Discard it immediately. Cloudiness indicates particulate contamination or protein aggregation, and discolouration (yellowing or browning) signals methionine oxidation. Properly reconstituted LIPO-C should be clear and colourless. Visual inspection cannot detect microbial contamination, but cloudiness and colour changes are definitive signs of compromised integrity. Injecting degraded formulations delivers inactive methionine sulfoxide instead of methionine, rendering the protocol ineffective.

Use the solution within 72 hours and refrigerate immediately. Sterile saline lacks the bacteriostatic agent (typically 0.9% benzyl alcohol) that inhibits microbial growth in multi-dose vials. Without it, each needle puncture introduces potential contamination that proliferates at refrigeration temperatures. Single-use vials reconstituted with sterile saline are acceptable if the entire volume is used immediately, but multi-dose protocols require bacteriostatic water to maintain sterility across 28 days of repeated draws.